Maravai LifeSciences Holdings, Inc. (MRVI) — 分析师展望 / 分析师共识目标价为. 基于 14 位分析师评级, 共识为 看涨 — 7 买入, 6 持有, 1 卖出.
分析师共识目标价为 $4.50, 上涨空间为 28.6% 相对于当前价格 $3.50.
分析师预估 每股收益(EPS)为 $-0.08 和 营收为 $0.26B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.05 vs 预期 $-0.08 (不及预期 -1239.4%). 2025: 实际 $-0.91 vs 预期 $-0.31 (不及预期 -191.3%). 分析师准确度: 21%.
MRVI 股票 — 12个月价格预测
$4.50
▲ +28.57% 上涨空间
平均目标价
Based on 14 Wall Street analysts offering 12-month price targets for Maravai LifeSciences Holdings, Inc., the price target is $4.50.
平均目标价相对最新价格 $3.50 变动 +28.57%。
MRVI 分析师评级
Buy
基于过去3个月内 14 位分析师对 Maravai LifeSciences Holdings, Inc. 的评级
EPS 预测 — MRVI
21%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.05
vs Est –$0.08
▼ 92.5% off
2025
Actual –$0.91
vs Est –$0.31
▼ 65.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — MRVI
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.259B
vs Est $0.260B
▼ 0.4% off
2025
Actual $0.186B
vs Est $0.185B
▲ 0.4% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
